Autobio(SH:603658)2018-04-24 16:00Financial Performance - Net profit attributable to shareholders rose by 42.43% to CNY 96,006,142.00 year-on-year[5] - Operating revenue surged by 71.87% to CNY 415,596,659.68 compared to the same period last year[5] - Basic earnings per share increased by 43.75% to CNY 0.23 compared to the previous year[5] - The weighted average return on equity improved by 1.58 percentage points to 5.60%[5] - The company anticipates continued growth in revenue driven by acquisitions and the ongoing success of its magnetic particle chemiluminescence testing reagents[13] Assets and Liabilities - Total assets increased by 6.17% to CNY 2,322,203,779.49 compared to the end of the previous year[5] - Total assets at the end of the reporting period amounted to RMB 1,007,802,921.79, up from RMB 913,690,359.60 at the beginning of the year[17] - Total liabilities increased to CNY 486,286,856.05 from CNY 448,134,222.84, representing a rise of about 8.5%[23] - Current liabilities totaled CNY 420,951,447.45, compared to CNY 385,377,824.32 at the start of the year, indicating an increase of approximately 9.5%[23] - Non-current liabilities amounted to CNY 65,335,408.60, up from CNY 62,756,398.52, showing a growth of about 4.1%[23] Cash Flow - Net cash flow from operating activities increased by 28.24% to CNY 113,533,646.38 year-on-year[5] - Cash flow from operating activities was CNY 477,784,037.17, an increase of 49.2% from CNY 320,350,840.24 in the same period last year[30] - Net cash outflow from investing activities was CNY -115,633,662.10, compared to CNY -17,454,729.55 in the prior period, indicating a significant increase in investment expenditures[32] - Net cash flow from financing activities was CNY 29,672,477.89, showing a positive cash inflow despite a slight increase in cash outflows for debt repayment and dividends[32] - The net increase in cash and cash equivalents was CNY 26,858,473.94, down from CNY 70,751,046.27 in the previous period, indicating a decrease in liquidity[32] Expenses - The company's sales expenses increased by 54.08% to RMB 86,397,569.17, driven by higher wages and travel costs associated with increased revenue[13] - The company reported a 104.79% increase in operating costs, totaling RMB 146,894,547.31, in line with the rise in operating revenue[13] - Income tax expense increased by 41.00% to RMB 13,955,421.20, corresponding to the rise in total profit[13] - The company incurred sales expenses of CNY 69,725,976.68, which is a 47.5% increase from CNY 47,209,717.27 in the previous year[27] - Management expenses for Q1 2018 were CNY 37,707,832.20, an increase of 25.9% compared to CNY 29,906,912.90 in Q1 2017[27] Shareholder Information - The total number of shareholders reached 10,126 at the end of the reporting period[10] - The largest shareholder, Zhengzhou Antu Industrial Co., Ltd., holds 67.49% of the shares, with 283,462,200 shares pledged[10] Other Financial Metrics - Non-recurring gains and losses totaled CNY 5,328,534.41 for the reporting period[9] - Cash and cash equivalents rose to CNY 31,518,426.11 from CNY 10,770,503.79, marking an increase of about 192.5%[21] - Accounts receivable decreased slightly to CNY 192,385,382.94 from CNY 194,230,483.17, a decline of about 1%[21] - Inventory increased to CNY 205,610,074.14 from CNY 196,957,795.95, representing a growth of approximately 4.3%[22] - Deferred tax assets rose to CNY 39,981,930.64 from CNY 34,964,211.85, an increase of about 14.5%[19]